DB6 COMPARISON OF THE COST-EFFECTIVENESS FOR BASAL-BOLUS THERAPY OF TYPE-1 DIABETES USING INSULIN DETEMIR INSULIN ASPART OR HUMAN INSULIN-BASED REGIMENS IN THE NETHERLANDS
Abstract
Authors
Valentine Wj K Wittrup-Jensen AJ Palmer S Roze